Form 4: Merck & Co. Executive Sells Shares
Insider Transaction (Form 4)
David R. Maraldo, EVP & Pres. MMD of Merck & Co., Inc., sold 18,706 shares of common stock on August 5, 2026 for $128.72 per share.
Summary
- Option exercise/conversion: acquired 6,311 Common Stock at $73.73 ($465,310) on August 5, 2026; holds 24,523 after (Direct).
- Open-market sale: disposed of 6,311 Common Stock at $128.72 ($812,339) on August 5, 2026; holds 18,212 after (Direct).
- Option exercise/conversion: acquired 9,709 Common Stock at $87.10 ($845,654) on August 5, 2026; holds 27,921 after (Direct).
- Open-market sale: disposed of 9,709 Common Stock at $128.72 ($1,249,722) on August 5, 2026; holds 18,212 after (Direct).
- Option exercise/conversion: acquired 2,686 Common Stock at $84.71 ($227,531) on August 5, 2026; holds 20,898 after (Direct).
- Open-market sale: disposed of 2,686 Common Stock at $128.72 ($345,736) on August 5, 2026; holds 18,212 after (Direct).
- Option exercise/conversion: disposed of 6,311 Stock Option (Right to Buy) on August 5, 2026; holds 3,154 after (Direct).
- Option exercise/conversion: disposed of 9,709 Stock Option (Right to Buy) on August 5, 2026 (Direct).
- Option exercise/conversion: disposed of 2,686 Stock Option (Right to Buy) on August 5, 2026; holds 5,374 after (Direct).
Sentiment
Score: 3
Explanation: StockSavvy.ai views this as a mildly negative signal: an insider sold $2,407,797 of stock on the open market.
Insider Transactions
David R. Maraldo — Officer (EVP & Pres. MMD)
| Date | Transaction | Security | Shares | Price | Value | Held After |
|---|---|---|---|---|---|---|
| 2026-08-05 | Option exercise/conversion | Common Stock | 6,311 | $74 | $465.3K | 24,523.434 |
| 2026-08-05 | Open-market sale | Common Stock | 6,311 | $129 | $812.3K | 18,212.434 |
| 2026-08-05 | Option exercise/conversion | Common Stock | 9,709 | $87 | $845.7K | 27,921.434 |
| 2026-08-05 | Open-market sale | Common Stock | 9,709 | $129 | $1.2M | 18,212.434 |
| 2026-08-05 | Option exercise/conversion | Common Stock | 2,686 | $85 | $227.5K | 20,898.434 |
| 2026-08-05 | Open-market sale | Common Stock | 2,686 | $129 | $345.7K | 18,212.434 |
| 2026-08-05 | Option exercise/conversion | Stock Option (Right to Buy) | 6,311 | — | — | 3,154 |
| 2026-08-05 | Option exercise/conversion | Stock Option (Right to Buy) | 9,709 | — | — | 0 |
| 2026-08-05 | Option exercise/conversion | Stock Option (Right to Buy) | 2,686 | — | — | 5,374 |
Key Dates
| Date | Description |
|---|---|
| 2026-08-05 | Option exercise/conversion (6,311 shares) |
| 2026-08-05 | Open-market sale (6,311 shares) |
| 2026-08-05 | Option exercise/conversion (9,709 shares) |
| 2026-08-05 | Open-market sale (9,709 shares) |
| 2026-08-05 | Option exercise/conversion (2,686 shares) |
| 2026-08-05 | Open-market sale (2,686 shares) |
| 2026-08-05 | Option exercise/conversion (6,311 shares) |
| 2026-08-05 | Option exercise/conversion (9,709 shares) |
| 2026-08-05 | Option exercise/conversion (2,686 shares) |
Keywords
insider transaction, Form 4, MRK, Merck & Co., Inc., bearish, David R. Maraldo
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.